UNSPSC 51181920: Cyclofenil

This classification denotes an antiestrogen with the molecular formula C23H24O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J468V64WZ1, chemically known as 4,4-(cyclohexylidenemethylene)diphenol diacetate ester but generally known as cyclofenil, which bears US NIH Compound Identifier 2898. European Medicines Agency schedules Cyclofenil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06852MIG.

UNSPSC 51181920 Cyclofenil, a Commodity code, covers pharmaceutical products supplied through state and local cooperative purchasing arrangements for distribution across government health facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued a Request for Proposal on January 20, 2026 for generic multi-source pharmaceuticals and over-the-counter products — a procurement vehicle designed to establish master contracts with multiple vendors that participating states and localities can draw from at pre-negotiated pricing. State and local buyers use this code primarily through cooperative purchasing agreements rather than individual jurisdictions issuing their own solicitations; the MMCAP structure allows member states and local health systems to access negotiated pharmaceutical pricing without running separate procurements. Vendors must supply products exclusively through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co.), hold cGMP and Drug Supply Chain Security Act compliance certifications, maintain contractual relationships with at least two of the three wholesalers, and provide detailed product specifications including National Drug Codes, SKUs, and UPCs.

The MMCAP cooperative, administered by the Minnesota Department of Administration's Office of State Procurement, includes Oregon as a participating member alongside Minnesota and other states. The RFP closes March 26, 2026, with pricing weighted primarily on competitiveness (75 percent) and fixed pricing for the contract term (10 percent), and awarded vendors will become effective July 1, 2026 for a two-year term with optional extensions. Vendors must carry commercial general liability coverage of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000, and will pay a 3 percent administrative fee on all contract purchases. The solicitation does not identify specific dollar amounts or set-aside restrictions, though performance violations carry penalties ranging from $200 to $1,500 per incident.